文献速递神经头颈儿科影像DSA

儿童视网膜母细胞瘤选择性眼动脉灌注化疗中技术与辅助因素与肿瘤定量缩小的相关性

Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-12-24

该单中心回顾性研究纳入21只既往未治疗眼,分析选择性眼动脉灌注化疗中动脉内维拉帕米、鼻内羟甲唑啉及颈外动脉球囊阻断等技术辅助因素与肿瘤定量缩小的关系。结果显示动脉内维拉帕米与满意疗效(肿瘤缩小≥50%)相关(P=0.03),在单药美法仑剂量<5 mg亚组中更显著(P=0.02),且该亚组中维拉帕米与更高的平均肿瘤缩小率相关(P<0.01)。

要点

  • 动脉内维拉帕米与满意疗效(肿瘤缩小≥50%)相关(P=0.03)。
  • 单药美法仑<5 mg亚组中维拉帕米与满意疗效相关(P=0.02)。
  • 该亚组中维拉帕米与更高的平均肿瘤缩小率相关(P<0.01)。

关键影像表现/征象

  • 肿瘤定量缩小范围为15%至95%。
  • 6只眼显示 dichotomous 治疗反应差(肿瘤缩小<50%)。

诊断标准与关键数值

  • 满意治疗反应定义为肿瘤定量缩小≥50%,差定义为<50%。
  • 满意治疗反应与动脉内维拉帕米相关(P=0.03)。
  • 单药美法仑剂量<5 mg亚组中,满意治疗反应与动脉内维拉帕米相关(P=0.02)。
  • 该亚组中,更高的平均肿瘤定量缩小与动脉内维拉帕米相关(P<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Selective ophthalmic artery infusion chemotherapy has improved ocular outcomes in children with retinoblastoma. Our aim was to correlate quantitative tumor reduction and dichotomous therapeutic response with technical and adjunctive factors during selective ophthalmic artery infusion chemotherapy for retinoblastoma. An understanding of such factors may improve therapeutic efficacy.

MATERIALS AND METHODS: All patients with retinoblastoma treated by selective ophthalmic artery infusion chemotherapy at a single center during a 9-year period were reviewed. Only first-cycle treatments for previously untreated eyes were studied. Adjunctive factors (intra-arterial verapamil, intranasal oxymetazoline external carotid balloon occlusion) and technical factors (chemotherapy infusion time, fluoroscopy time) were documented by medical record review. Quantitative tumor reduction was determined by blinded comparison of retinal imaging acquired during examination under anesthesia before and 3-4 weeks after treatment. The dichotomous therapeutic response was classified according to quantitative tumor reduction as satisfactory (≥ 50%) or poor (<50%).

RESULTS: Twenty-one eyes met the inclusion criteria. Patients ranged from 2 to 59 months of age. Adjuncts included intra-arterial verapamil in 15, intranasal oxymetazoline in 14, and external carotid balloon occlusion in 14. Quantitative tumor reduction ranged from 15% to 95%. Six showed poor dichotomous therapeutic response. A satisfactory dichotomous therapeutic response was correlated with intra-arterial verapamil (P = .03) in the aggregate cohort and in a subgroup undergoing treatment with single-agent melphalan at a dose of <5 mg (P = .02). In the latter, higher average quantitative tumor reduction correlated with intra-arterial verapamil (P < .01).

CONCLUSIONS: Intra-arterial verapamil during selective ophthalmic artery infusion chemotherapy is correlated with an improved therapeutic response, particularly when treating with lower doses of single-agent melphalan.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Abruzzo T, Abraham K, Karani KB, et al. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. AJNR Am J Neuroradiol. 2020. PMID: 33361377. doi:10.3174/ajnr.A6905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。